For a third season, COVID-19 cases are rising ahead of the holidays, this time with a more recent variant driving infections.
Cases of JN. 1 infections rose from just more than 8% at the end of November to double digits by Dec. 9, according to CDC data.
International health experts say the sudden jump isn’t cause for concern—yet.
Here’s what you need to know:
What is JN.1?
The JN.1 variant is closely related to another omicron subvariant named BA.2.86, according to the CDC.
Health officials started tracking BA.2.86 in August but noticed some cases had a single change to the spike protein, the part of a virus that penetrates host cells to cause infection, according to the CDC.
JN.1 was first detected as its own variant in the United States in September, the CDC reported, and has since been identified in 11 countries.
The variant made up just 0.1% of cases at the end of October, according to CDC data, but that number has now increased exponentially.
“The continued growth of JN.1 suggests that it is either more transmissible or better at evading our immune systems,” the CDC said at the beginning of December.
This means the change to the spike protein may make it easier for the virus to get into cells than previous variants or make it harder for human immune systems to identify the virus as COVID-19.
International health experts also noted the trend, with JN.1 officially classified as its own variant by the World Health Organization on Dec. 19.
“Based on the available evidence, the additional global public health risk posed by JN.1 is currently evaluated as low,” the WHO said in a post on X, formerly known as Twitter. “Despite this, with the onset of winter in the Northern Hemisphere, JN.1 could increase the burden of respiratory infections in many countries.”
Does the updated COVID booster protect against JN.1?
The CDC says the JN.1 variant is closely related enough to previous variants that the updated COVID-19 booster shot will provide protection.
“The spike protein—called a ‘spike’ because it looks like tiny spikes on the virus’ surface—plays a crucial role in helping the virus infect people. Because of this, the spike protein is also the part of the virus that vaccines target, meaning vaccines should work against JN.1 and BA.2.86 similarly,” the CDC said.
The agency continued by saying it expects “treatments and testing to remain effective” against JN.1, in line with previous variants.
The most recent COVID-19 booster was approved by the Food and Drug Administration and then recommended by the CDC in September, but a large number of Americans have opted out of the shot.
Do I need the new COVID booster?
The vaccine is recommended for everyone over the age of six months, regardless of previous vaccine status, the CDC says.
Despite this, fewer and fewer Americans are adding the shot to their regular seasonal vaccines, like the flu shot.
By the middle of November, only 36 million adults and 3.5 million children had received the latest shot, equivalent to about 14% of the American public, ABC News reported.
That’s compared to the nearly 70% of Americans who completed the primary series of COVID-19 vaccines, McClatchy News reported.
Cases of JN.1 have seen some of the highest increases in Midwestern states, CDC data shows, correlating with a pocket of the U.S. that has been particularly hesitant to get the new shot.
Ahead of the holidays, the CDC reiterated the vaccine, masking and keeping your distance when you might be sick are still the most effective ways to prevent a COVID-19 infection and prevent its spread.
The agency said this also extends to other respiratory illnesses making the rounds this season.
“Many viruses spread more during the holiday season, so it is important to get all recommended vaccines, including flu, COVID-19 and RSV, as soon as possible,” the CDC said. “This will give you the best protection against these respiratory diseases, including while traveling and gathering with family and friends. These vaccines will also make your illness less severe if you do get sick.”
News
Why More People in Their 30s Are Suddenly Getting Colon Cancer
A major Swiss study found that colorectal cancer is becoming increasingly common in adults under 50, even as rates decline in older age groups. Researchers in Switzerland have identified a concerning trend: while colorectal [...]
Researchers Compare MS Models to Human Tissue in Search for Better Therapies
Researchers identified key differences between two widely used multiple sclerosis models, showing how each can better study myelin damage, immune responses, and repair. The findings may improve efforts to develop treatments that restore lost [...]
Scientists Discover Genetic “Off Switch” That Supercharges CAR T Cells Against Cancer
A new study reveals a possible way to make CAR T-cell therapy more durable and effective by targeting a single gene-regulating protein. CAR T-cell therapy is widely seen as a breakthrough in personalized cancer [...]
New Vitamin B12-Based Therapy Could Change How Brain Cancer Is Treated
Researchers have identified a vitamin B12–based compound that appears capable of crossing the blood–brain barrier and selectively accumulating in glioblastoma tissue. For decades, one of the biggest problems in brain cancer treatment has had [...]
Simple Fiber Supplement Cuts Knee Arthritis Pain in Just 6 Weeks, Study Finds
A daily inulin supplement may help reduce knee osteoarthritis pain while revealing a possible link between gut health, muscle function, and pain sensitivity. For millions of people living with knee osteoarthritis, managing chronic pain [...]
This Common Vitamin May Help Stop Prediabetes From Turning Into Diabetes
Vitamin D may help prevent type 2 diabetes in people with specific genetic variations, offering a possible path toward personalized diabetes prevention. More than 40% of U.S. adults have prediabetes, a condition in which [...]
Ebola, hantavirus: Is the world prepared for the next pandemic?
Funding cuts to health research and a growing antivaccine movement are making it harder than ever to respond to viruses. The World Health Organization (WHO) has declared that an Ebola outbreak in Uganda and [...]
May 2026 Healthcare News and Trends: Market Signals That Matter
Artificial intelligence is dominating headlines, telehealth has settled into a new normal, and digital health continues to promise transformation. However, much of what is being discussed in healthcare today reflects potential rather than reality. [...]
Scientists Rewire Donor Stem Cells To Outsmart Aggressive Blood Cancers
Researchers have tested a gene-edited stem cell transplant designed to shield healthy blood-forming cells from powerful cancer-targeting immunotherapies. For patients with highly aggressive blood cancers, stem cell transplantation can offer a rare chance at [...]
Recent Digital Health Trends, Insights and News – May 2026
Last month marked continued progress as digital health moves into its next phase — from AI expanding into drug discovery and core infrastructure to new federal pathways accelerating device access and home-based care. Together, [...]
Cancer Mystery Solved: Scientists Discover How Melanoma Becomes “Immortal”
Scientists have uncovered a previously overlooked mechanism that may help melanoma cells become effectively “immortal.” Cancer cells face a major problem before they can become deadly: They have to figure out how to stop [...]
How Visual Neurons Organize Thousands of Synaptic Inputs
Summary: A new study uncovered the organizational rules that determine how neurons in the primary visual cortex process information. By imaging both the cell bodies (soma) and the individual synapses (on dendritic spines) of [...]
Scientists Just Found a Surprising Way To Destroy “Forever Chemicals”
Scientists have uncovered a new mechanism that may help break down highly persistent PFAS pollutants. PFAS have earned the nickname “forever chemicals” for a reason. These industrial compounds are so chemically durable that they [...]
Scientists Discover Cheap Material That Kills Deadly Superbugs
A new sulfur-rich antimicrobial polymer shows strong effectiveness against fungal and bacterial pathogens and may offer an affordable solution to antimicrobial resistance. Antimicrobial resistance is creating growing challenges for both healthcare and food production, [...]
What to Know About Cicada, or BA.3.2, the Latest SARS-CoV-2 Variant Under Monitoring
Like periodical cicadas, the insects for which it is nicknamed, SARS-CoV-2 Omicron subvariant BA.3.2 is only just beginning to emerge after lying low for an extended period since it first appeared. Although it was [...]
Scientists Say This Simple Supplement May Actually Reverse Heart Disease
Scientists in Japan say a common supplement may actually help “unclog” certain diseased heart arteries from the inside out. A simple food supplement sold in Japan may have helped reverse a dangerous form of [...]
